世界の多形性膠芽腫治療（GBM）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Glioblastoma Multiforme Treatment (GBM) Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2585
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、多形性膠芽腫治療（GBM）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、遺伝子治療、分子バイオテクノロジー）、用途別市場規模（病院・クリニック、ASC、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・多形性膠芽腫治療（GBM）の市場動向
・企業の競争状況、市場シェア
・多形性膠芽腫治療（GBM）の種類別市場規模（化学療法、放射線療法、遺伝子治療、分子バイオテクノロジー）
・多形性膠芽腫治療（GBM）の用途別市場規模（病院・クリニック、ASC、その他）
・多形性膠芽腫治療（GBM）の北米市場規模2016-2027（アメリカ、カナダ）
・多形性膠芽腫治療（GBM）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・多形性膠芽腫治療（GBM）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・多形性膠芽腫治療（GBM）の中南米市場規模2016-2027（メキシコ、ブラジル）
・多形性膠芽腫治療（GBM）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Merck、Teva Pharmaceutical、Arbor Pharmaceuticals、Sun Pharmaceutical、Roche）
・結論

Market Analysis and Insights: Global Glioblastoma Multiforme Treatment (GBM) Market
The global Glioblastoma Multiforme Treatment (GBM) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Glioblastoma Multiforme Treatment (GBM) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Glioblastoma Multiforme Treatment (GBM) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Glioblastoma Multiforme Treatment (GBM) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Glioblastoma Multiforme Treatment (GBM) market.

Global Glioblastoma Multiforme Treatment (GBM) Scope and Market Size
Glioblastoma Multiforme Treatment (GBM) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Glioblastoma Multiforme Treatment (GBM) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Chemotherapy
Radiotherapy
Gene therapy
Molecular biotechnology

Segment by Application
Hospital & Clinic
ASCs
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Merck
Teva Pharmaceutical
Arbor Pharmaceuticals
Sun Pharmaceutical
Roche

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Glioblastoma Multiforme Treatment (GBM) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Radiotherapy
1.2.4 Gene therapy
1.2.5 Molecular biotechnology
1.3 Market by Application
1.3.1 Global Glioblastoma Multiforme Treatment (GBM) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital & Clinic
1.3.3 ASCs
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Glioblastoma Multiforme Treatment (GBM) Market Perspective (2016-2027)
2.2 Glioblastoma Multiforme Treatment (GBM) Growth Trends by Regions
2.2.1 Glioblastoma Multiforme Treatment (GBM) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Glioblastoma Multiforme Treatment (GBM) Historic Market Share by Regions (2016-2021)
2.2.3 Glioblastoma Multiforme Treatment (GBM) Forecasted Market Size by Regions (2022-2027)
2.3 Glioblastoma Multiforme Treatment (GBM) Industry Dynamic
2.3.1 Glioblastoma Multiforme Treatment (GBM) Market Trends
2.3.2 Glioblastoma Multiforme Treatment (GBM) Market Drivers
2.3.3 Glioblastoma Multiforme Treatment (GBM) Market Challenges
2.3.4 Glioblastoma Multiforme Treatment (GBM) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Glioblastoma Multiforme Treatment (GBM) Players by Revenue
3.1.1 Global Top Glioblastoma Multiforme Treatment (GBM) Players by Revenue (2016-2021)
3.1.2 Global Glioblastoma Multiforme Treatment (GBM) Revenue Market Share by Players (2016-2021)
3.2 Global Glioblastoma Multiforme Treatment (GBM) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Glioblastoma Multiforme Treatment (GBM) Revenue
3.4 Global Glioblastoma Multiforme Treatment (GBM) Market Concentration Ratio
3.4.1 Global Glioblastoma Multiforme Treatment (GBM) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Glioblastoma Multiforme Treatment (GBM) Revenue in 2020
3.5 Glioblastoma Multiforme Treatment (GBM) Key Players Head office and Area Served
3.6 Key Players Glioblastoma Multiforme Treatment (GBM) Product Solution and Service
3.7 Date of Enter into Glioblastoma Multiforme Treatment (GBM) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Glioblastoma Multiforme Treatment (GBM) Breakdown Data by Type
4.1 Global Glioblastoma Multiforme Treatment (GBM) Historic Market Size by Type (2016-2021)
4.2 Global Glioblastoma Multiforme Treatment (GBM) Forecasted Market Size by Type (2022-2027)

5 Glioblastoma Multiforme Treatment (GBM) Breakdown Data by Application
5.1 Global Glioblastoma Multiforme Treatment (GBM) Historic Market Size by Application (2016-2021)
5.2 Global Glioblastoma Multiforme Treatment (GBM) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Glioblastoma Multiforme Treatment (GBM) Market Size (2016-2027)
6.2 North America Glioblastoma Multiforme Treatment (GBM) Market Size by Type
6.2.1 North America Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2016-2021)
6.2.2 North America Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2022-2027)
6.2.3 North America Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2016-2027)
6.3 North America Glioblastoma Multiforme Treatment (GBM) Market Size by Application
6.3.1 North America Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2016-2021)
6.3.2 North America Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2022-2027)
6.3.3 North America Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2016-2027)
6.4 North America Glioblastoma Multiforme Treatment (GBM) Market Size by Country
6.4.1 North America Glioblastoma Multiforme Treatment (GBM) Market Size by Country (2016-2021)
6.4.2 North America Glioblastoma Multiforme Treatment (GBM) Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Glioblastoma Multiforme Treatment (GBM) Market Size (2016-2027)
7.2 Europe Glioblastoma Multiforme Treatment (GBM) Market Size by Type
7.2.1 Europe Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2016-2021)
7.2.2 Europe Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2022-2027)
7.2.3 Europe Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2016-2027)
7.3 Europe Glioblastoma Multiforme Treatment (GBM) Market Size by Application
7.3.1 Europe Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2016-2021)
7.3.2 Europe Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2022-2027)
7.3.3 Europe Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2016-2027)
7.4 Europe Glioblastoma Multiforme Treatment (GBM) Market Size by Country
7.4.1 Europe Glioblastoma Multiforme Treatment (GBM) Market Size by Country (2016-2021)
7.4.2 Europe Glioblastoma Multiforme Treatment (GBM) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Glioblastoma Multiforme Treatment (GBM) Market Size (2016-2027)
8.2 Asia-Pacific Glioblastoma Multiforme Treatment (GBM) Market Size by Type
8.2.1 Asia-Pacific Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2016-2027)
8.3 Asia-Pacific Glioblastoma Multiforme Treatment (GBM) Market Size by Application
8.3.1 Asia-Pacific Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2016-2027)
8.4 Asia-Pacific Glioblastoma Multiforme Treatment (GBM) Market Size by Region
8.4.1 Asia-Pacific Glioblastoma Multiforme Treatment (GBM) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Glioblastoma Multiforme Treatment (GBM) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Glioblastoma Multiforme Treatment (GBM) Market Size (2016-2027)
9.2 Latin America Glioblastoma Multiforme Treatment (GBM) Market Size by Type
9.2.1 Latin America Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2016-2021)
9.2.2 Latin America Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2022-2027)
9.2.3 Latin America Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2016-2027)
9.3 Latin America Glioblastoma Multiforme Treatment (GBM) Market Size by Application
9.3.1 Latin America Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2016-2021)
9.3.2 Latin America Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2022-2027)
9.3.3 Latin America Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2016-2027)
9.4 Latin America Glioblastoma Multiforme Treatment (GBM) Market Size by Country
9.4.1 Latin America Glioblastoma Multiforme Treatment (GBM) Market Size by Country (2016-2021)
9.4.2 Latin America Glioblastoma Multiforme Treatment (GBM) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Glioblastoma Multiforme Treatment (GBM) Market Size (2016-2027)
10.2 Middle East & Africa Glioblastoma Multiforme Treatment (GBM) Market Size by Type
10.2.1 Middle East & Africa Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2016-2027)
10.3 Middle East & Africa Glioblastoma Multiforme Treatment (GBM) Market Size by Application
10.3.1 Middle East & Africa Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2016-2027)
10.4 Middle East & Africa Glioblastoma Multiforme Treatment (GBM) Market Size by Country
10.4.1 Middle East & Africa Glioblastoma Multiforme Treatment (GBM) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Glioblastoma Multiforme Treatment (GBM) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Glioblastoma Multiforme Treatment (GBM) Introduction
11.1.4 Merck Revenue in Glioblastoma Multiforme Treatment (GBM) Business (2016-2021)
11.1.5 Merck Recent Development
11.2 Teva Pharmaceutical
11.2.1 Teva Pharmaceutical Company Details
11.2.2 Teva Pharmaceutical Business Overview
11.2.3 Teva Pharmaceutical Glioblastoma Multiforme Treatment (GBM) Introduction
11.2.4 Teva Pharmaceutical Revenue in Glioblastoma Multiforme Treatment (GBM) Business (2016-2021)
11.2.5 Teva Pharmaceutical Recent Development
11.3 Arbor Pharmaceuticals
11.3.1 Arbor Pharmaceuticals Company Details
11.3.2 Arbor Pharmaceuticals Business Overview
11.3.3 Arbor Pharmaceuticals Glioblastoma Multiforme Treatment (GBM) Introduction
11.3.4 Arbor Pharmaceuticals Revenue in Glioblastoma Multiforme Treatment (GBM) Business (2016-2021)
11.3.5 Arbor Pharmaceuticals Recent Development
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Company Details
11.4.2 Sun Pharmaceutical Business Overview
11.4.3 Sun Pharmaceutical Glioblastoma Multiforme Treatment (GBM) Introduction
11.4.4 Sun Pharmaceutical Revenue in Glioblastoma Multiforme Treatment (GBM) Business (2016-2021)
11.4.5 Sun Pharmaceutical Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Glioblastoma Multiforme Treatment (GBM) Introduction
11.5.4 Roche Revenue in Glioblastoma Multiforme Treatment (GBM) Business (2016-2021)
11.5.5 Roche Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Glioblastoma Multiforme Treatment (GBM) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Radiotherapy
Table 4. Key Players of Gene therapy
Table 5. Key Players of Molecular biotechnology
Table 6. Global Glioblastoma Multiforme Treatment (GBM) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Glioblastoma Multiforme Treatment (GBM) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Glioblastoma Multiforme Treatment (GBM) Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Glioblastoma Multiforme Treatment (GBM) Market Share by Regions (2016-2021)
Table 10. Global Glioblastoma Multiforme Treatment (GBM) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Glioblastoma Multiforme Treatment (GBM) Market Share by Regions (2022-2027)
Table 12. Glioblastoma Multiforme Treatment (GBM) Market Trends
Table 13. Glioblastoma Multiforme Treatment (GBM) Market Drivers
Table 14. Glioblastoma Multiforme Treatment (GBM) Market Challenges
Table 15. Glioblastoma Multiforme Treatment (GBM) Market Restraints
Table 16. Global Glioblastoma Multiforme Treatment (GBM) Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Glioblastoma Multiforme Treatment (GBM) Market Share by Players (2016-2021)
Table 18. Global Top Glioblastoma Multiforme Treatment (GBM) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glioblastoma Multiforme Treatment (GBM) as of 2020)
Table 19. Ranking of Global Top Glioblastoma Multiforme Treatment (GBM) Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Glioblastoma Multiforme Treatment (GBM) Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Glioblastoma Multiforme Treatment (GBM) Product Solution and Service
Table 23. Date of Enter into Glioblastoma Multiforme Treatment (GBM) Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Glioblastoma Multiforme Treatment (GBM) Revenue Market Share by Type (2016-2021)
Table 27. Global Glioblastoma Multiforme Treatment (GBM) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Glioblastoma Multiforme Treatment (GBM) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Glioblastoma Multiforme Treatment (GBM) Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Glioblastoma Multiforme Treatment (GBM) Revenue Market Share by Application (2016-2021)
Table 31. Global Glioblastoma Multiforme Treatment (GBM) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Glioblastoma Multiforme Treatment (GBM) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Glioblastoma Multiforme Treatment (GBM) Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Glioblastoma Multiforme Treatment (GBM) Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Glioblastoma Multiforme Treatment (GBM) Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Glioblastoma Multiforme Treatment (GBM) Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Glioblastoma Multiforme Treatment (GBM) Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Glioblastoma Multiforme Treatment (GBM) Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Glioblastoma Multiforme Treatment (GBM) Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Glioblastoma Multiforme Treatment (GBM) Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Glioblastoma Multiforme Treatment (GBM) Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Glioblastoma Multiforme Treatment (GBM) Market Size by Country (2022-2027) & (US$ Million)
Table 63. Merck Company Details
Table 64. Merck Business Overview
Table 65. Merck Glioblastoma Multiforme Treatment (GBM) Product
Table 66. Merck Revenue in Glioblastoma Multiforme Treatment (GBM) Business (2016-2021) & (US$ Million)
Table 67. Merck Recent Development
Table 68. Teva Pharmaceutical Company Details
Table 69. Teva Pharmaceutical Business Overview
Table 70. Teva Pharmaceutical Glioblastoma Multiforme Treatment (GBM) Product
Table 71. Teva Pharmaceutical Revenue in Glioblastoma Multiforme Treatment (GBM) Business (2016-2021) & (US$ Million)
Table 72. Teva Pharmaceutical Recent Development
Table 73. Arbor Pharmaceuticals Company Details
Table 74. Arbor Pharmaceuticals Business Overview
Table 75. Arbor Pharmaceuticals Glioblastoma Multiforme Treatment (GBM) Product
Table 76. Arbor Pharmaceuticals Revenue in Glioblastoma Multiforme Treatment (GBM) Business (2016-2021) & (US$ Million)
Table 77. Arbor Pharmaceuticals Recent Development
Table 78. Sun Pharmaceutical Company Details
Table 79. Sun Pharmaceutical Business Overview
Table 80. Sun Pharmaceutical Glioblastoma Multiforme Treatment (GBM) Product
Table 81. Sun Pharmaceutical Revenue in Glioblastoma Multiforme Treatment (GBM) Business (2016-2021) & (US$ Million)
Table 82. Sun Pharmaceutical Recent Development
Table 83. Roche Company Details
Table 84. Roche Business Overview
Table 85. Roche Glioblastoma Multiforme Treatment (GBM) Product
Table 86. Roche Revenue in Glioblastoma Multiforme Treatment (GBM) Business (2016-2021) & (US$ Million)
Table 87. Roche Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Glioblastoma Multiforme Treatment (GBM) Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Radiotherapy Features
Figure 4. Gene therapy Features
Figure 5. Molecular biotechnology Features
Figure 6. Global Glioblastoma Multiforme Treatment (GBM) Market Share by Application: 2020 VS 2027
Figure 7. Hospital & Clinic Case Studies
Figure 8. ASCs Case Studies
Figure 9. Others Case Studies
Figure 10. Glioblastoma Multiforme Treatment (GBM) Report Years Considered
Figure 11. Global Glioblastoma Multiforme Treatment (GBM) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Glioblastoma Multiforme Treatment (GBM) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Glioblastoma Multiforme Treatment (GBM) Market Share by Regions: 2020 VS 2027
Figure 14. Global Glioblastoma Multiforme Treatment (GBM) Market Share by Regions (2022-2027)
Figure 15. Global Glioblastoma Multiforme Treatment (GBM) Market Share by Players in 2020
Figure 16. Global Top Glioblastoma Multiforme Treatment (GBM) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glioblastoma Multiforme Treatment (GBM) as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Glioblastoma Multiforme Treatment (GBM) Revenue in 2020
Figure 18. Global Glioblastoma Multiforme Treatment (GBM) Revenue Market Share by Type (2016-2021)
Figure 19. Global Glioblastoma Multiforme Treatment (GBM) Revenue Market Share by Type (2022-2027)
Figure 20. North America Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Glioblastoma Multiforme Treatment (GBM) Market Share by Type (2016-2027)
Figure 22. North America Glioblastoma Multiforme Treatment (GBM) Market Share by Application (2016-2027)
Figure 23. North America Glioblastoma Multiforme Treatment (GBM) Market Share by Country (2016-2027)
Figure 24. United States Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Glioblastoma Multiforme Treatment (GBM) Market Share by Type (2016-2027)
Figure 28. Europe Glioblastoma Multiforme Treatment (GBM) Market Share by Application (2016-2027)
Figure 29. Europe Glioblastoma Multiforme Treatment (GBM) Market Share by Country (2016-2027)
Figure 30. Germany Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Glioblastoma Multiforme Treatment (GBM) Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Glioblastoma Multiforme Treatment (GBM) Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Glioblastoma Multiforme Treatment (GBM) Market Share by Region (2016-2027)
Figure 40. China Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Glioblastoma Multiforme Treatment (GBM) Market Share by Type (2016-2027)
Figure 48. Latin America Glioblastoma Multiforme Treatment (GBM) Market Share by Application (2016-2027)
Figure 49. Latin America Glioblastoma Multiforme Treatment (GBM) Market Share by Country (2016-2027)
Figure 50. Mexico Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Glioblastoma Multiforme Treatment (GBM) Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Glioblastoma Multiforme Treatment (GBM) Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Glioblastoma Multiforme Treatment (GBM) Market Share by Country (2016-2027)
Figure 56. Turkey Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Merck Revenue Growth Rate in Glioblastoma Multiforme Treatment (GBM) Business (2016-2021)
Figure 60. Teva Pharmaceutical Revenue Growth Rate in Glioblastoma Multiforme Treatment (GBM) Business (2016-2021)
Figure 61. Arbor Pharmaceuticals Revenue Growth Rate in Glioblastoma Multiforme Treatment (GBM) Business (2016-2021)
Figure 62. Sun Pharmaceutical Revenue Growth Rate in Glioblastoma Multiforme Treatment (GBM) Business (2016-2021)
Figure 63. Roche Revenue Growth Rate in Glioblastoma Multiforme Treatment (GBM) Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4963 2021年4月 91Pages
QYResearch社発行の本調査資料では、再発性多形性膠芽腫（GBM）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、テモゾロミド、放射線増感剤、ニトロソウレア薬、放射線療法、化学療法）、用途別市場規模（病院、診療所、外来手術セン...

世界の多形性膠芽腫治療市場規模・現状・予測（2021年-2027年）

Global Glioblastoma Multiforme Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2586 2021年4月 97Pages
QYResearch社発行の本調査資料では、多形性膠芽腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ベバシズマブ（アバスチン）、カルムスチン（BiCNU）、テモゾロミド（テモダー・テモーダル・テムカッド））、用途別市場規模（病院、クリニ...

世界の再発性多形性膠芽腫治療市場規模・現状・予測（2021年-2027年）

Global Recurrent Glioblastoma Multiforme Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4964 2021年4月 128Pages
QYResearch社発行の本調査資料では、再発性多形性膠芽腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（AU-105、アキシチニブ、AXL-1717、AZD-7451、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規...

世界の多形性膠芽腫（GBM）治療市場規模・現状・予測（2021年-2027年）

Global Glioblastoma Multiforme (GBM) Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z2584 2021年4月 92Pages
QYResearch社発行の本調査資料では、多形性膠芽腫（GBM）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、標的薬物療法、放射線療法）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッ...

世界の糖尿病性ニューロパチー治療（DN）市場規模・現状・予測（2021年-2027年）

Global Diabetic Neuropathy Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1836 2021年4月 92Pages
QYResearch社発行の本調査資料では、糖尿病性ニューロパチー治療（DN）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（末梢神経障害、自律神経障害、近位神経障害、限局性神経障害）、用途別市場規模（病院、クリニック、薬局）、主要地域別市場規...

世界の糖尿病性ニューロパチー治療（DN）市場規模・現状・予測（2021年-2027年）

世界の皮膚糸状菌性爪真菌症治療（DOT）市場規模・現状・予測（2021年-2027年）

Global Dermatophytic Onychomycosis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1806 2021年4月 96Pages
QYResearch社発行の本調査資料では、皮膚糸状菌性爪真菌症治療（DOT）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（全身療法、局所療法、その他）、用途別市場規模（病院、皮膚科クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨ...

世界の気道感染症治療市場規模・現状・予測（2021年-2027年）

Global Respiratory Tract Infection Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5010 2021年4月 93Pages
QYResearch社発行の本調査資料では、気道感染症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、非ステロイド性抗炎症薬、咳止め薬、鼻充血緩和剤、その他）、用途別市場規模（病院、診療所）、主要地域別市場規模（北米、アメリカ、...

世界の気道感染症治療市場規模・現状・予測（2021年-2027年）

世界の疥癬治療市場規模・現状・予測（2021年-2027年）

Global Scabies Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5120 2021年4月 98Pages
QYResearch社発行の本調査資料では、疥癬治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（軟膏、併用薬、その他）、用途別市場規模（病院、在宅医療、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本...

世界の再発性多形性膠芽腫（GBM）治療市場規模・現状・予測（2021年-2027年） Recurrent glioblastoma multiforme is the most aggressive cancer that begins within the brain. The increasing incidence of seizure is expected to drive the recurrent glioblastoma multiforme treatment market. Market Analysis and Insights: Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market…
世界の多形性膠芽腫治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Glioblastoma Multiforme Treatment Market The global Glioblastoma Multiforme Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high da…
世界の再発性多形性膠芽腫治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Recurrent Glioblastoma Multiforme Treatment Market The global Recurrent Glioblastoma Multiforme Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in …
世界の多形性膠芽腫（GBM）治療市場規模・現状・予測（2021年-2027年） Glioblastoma multiforme (GBM) is among the most difficult of tumors to treat, and despite all efforts, median overall survival remains at approximately 12 months. Malignant gliomas are included in the category of rare diseases, and the orphan drug status is granted for the drug candidates in the pip…
世界のがん遺伝子治療市場規模・現状・予測（2021年-2027年） Gene therapy refers to the introduction of foreign genes into target cells to correct or compensate for diseases caused by gene defects and/or abnormal gene expression. Market Analysis and Insights: Global Gene Therapy For Cancer Market The global Gene Therapy For Cancer market size is projected to …